Jason Coleman, MS, ATC | |
208 University Dr, West Liberty, WV 26074-1082 | |
(304) 336-8093 | |
Not Available |
Full Name | Jason Coleman |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation - Sports Medicine |
Location | 208 University Dr, West Liberty, West Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831708221 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | AT001314 (West Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jason Coleman, MS, ATC 703 Stone Shannon Rd, Wheeling, WV 26003-6744 Ph: (304) 312-8463 | Jason Coleman, MS, ATC 208 University Dr, West Liberty, WV 26074-1082 Ph: (304) 336-8093 |
News Archive
Researchers from Brighton and Sussex Medical School have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.
Medtronic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its Arctic FrontĀ® Cardiac CryoAblation Catheter system, the first and only Cryoballoon in the United States indicated for the treatment of drug refractory paroxysmal atrial fibrillation (PAF). The Cryoballoon treatment involves a minimally-invasive procedure that efficiently creates circumferential lesions around the pulmonary vein, which is the source of erratic electrical signals that cause the irregular heartbeat.
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of August 25, 2011 for the review of the New Drug Application (NDA) for FIRAZYR(R) (icatibant) for the treatment of acute attacks (Types I and II) of hereditary angioedema (HAE). This 6 month review timeline is consistent with review as a Class II resubmission.
The largest UK study of psychological distress among ethnic minority adolescents has found higher rates of depressive symptoms among non-UK White pupils compared with White UK pupils.
› Verified 8 days ago